Abstract

Pulmonary Hypertension Clinical Trials and COVID-19: A Discussion With John Ryan and Roham Zamanian

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Treating Pulmonary Vascular Disease in the Developing World: The Single Step
Kamal K Mubarak ... Julio Sandoval
Chest | VOL. 137
Kamal K Mubarak, et. al.Kamal K Mubarak ... Julio Sandoval
01 Jun 2010
Health Disparities in Pulmonary Arterial Hypertension and the Impact of the COVID-19 Pandemic
John J Ryan ... Jeanna T Ryan
Advances in Pulmonary Hypertension | VOL. 20
John J Ryan, et. al.John J Ryan ... Jeanna T Ryan
01 Jan 2020
Prognosis of Pulmonary Arterial Hypertension
Vallerie V Mclaughlin ... Samy Suissa
Circulation | VOL. 122
Vallerie V Mclaughlin, et. al.Vallerie V Mclaughlin ... Samy Suissa
28 Jun 2010
Prediction of patient outcomes through social determinants of health: The Pulmonary Hypertension Association Registry (PHAR) evaluation.
Christine Dewilde ... Roham Zamanian
Pulmonary circulation | VOL. 12
Christine Dewilde, et. al.Christine Dewilde ... Roham Zamanian
01 Jul 2022
View more papers

More From: Advances in Pulmonary Hypertension

Paper Title
Journal
Date
Author
Full Issue PDF
-
Advances in Pulmonary Hypertension | VOL. 22
--
01 Dec 2023
PH Roundtable: Use of Off-Label PAH Therapies
-
Advances in Pulmonary Hypertension | VOL. 22
--
01 Dec 2023
Sarcoidosis-Associated Pulmonary Hypertension
H James Ford ... Mazen O Al-Qadi
Advances in Pulmonary Hypertension | VOL. 22
H James Ford, et. al.H James Ford ... Mazen O Al-Qadi
01 Dec 2023
Pulmonary Veno-Occlusive Disease
David Montani ... Salma Al Kahf
Advances in Pulmonary Hypertension | VOL. 22
David Montani, et. al.David Montani ... Salma Al Kahf
01 Dec 2023
View more papers